Table 1.
Baseline characteristics of HIV-infected women who received Pap smear screening in HIV care and treatment clinics (n=1365).
| Abnormal Pap smeara |
||
|---|---|---|
| No (n = 1246) | Yes (n = 119) | |
| Age group, years, n (%) | ||
| <30 | 275 (22.0) | 17 (14.3) |
| 30–<40 | 584 (46.9) | 57 (47.9) |
| 40–<50 | 305 (24.2) | 27 (22.7) |
| ≥50 | 82 (6.6) | 18 (15.1) |
| Married, n (%) | 463 (38.7) | 45 (38.8) |
| Calendar year of screening, n (%) | ||
| 2006 and 2007 | 327 (26.3) | 43 (36.1) |
| 2008 | 358 (28.7) | 39 (32.8) |
| 2009 | 561 (45.0) | 37 (31.1) |
| BMI, kg/m2, n (%) | ||
| <18.5 | 247 (19.8) | 27 (22.9) |
| 18.5–<25 | 691 (55.5) | 70 (59.3) |
| 25–<30 | 220 (17.7) | 16 (13.6) |
| ≥30 | 87 (7.0) | 5 (4.2) |
| Haemoglobin, g/dL, n (%) | ||
| <8.5 | 198 (16.7) | 25 (21.9) |
| 8.6–<10 | 340 (28.6) | 30 (26.3) |
| 10—<12 | 470 (39.5) | 30 (39.5) |
| ≥12 | 181 (15.3 | 14 (12.3) |
| CD4 + count, cells/mm3, n (%) | ||
| <50 | 184 (15.6) | 19 (16.4) |
| 50–<100 | 168 (14.3) | 29 (25.0) |
| 100–<200 | 394 (33.5) | 34 (29.3) |
| ≥200 | 431 (36.6) | 34 (29.3) |
| WHO stage, n (%) | ||
| I | 105 (8.4) | 13 (11.0) |
| II | 270 (21.7) | 20 (17.0) |
| III | 759 (61.1) | 65 (55.1) |
| IV | 109 (8.8) | 20 (16.9) |
| Current pregnancy, n (%) | 15(1.2) | 1 (0.8) |
| Months on ART, n (%) | ||
| Not on ART | 112 (9.0) | 11 (9.3) |
| >0 and <2 | 928 (74.5) | 85 (71.4) |
| ≥2 | 206 (16.5) | 23 (19.3) |
| Cervical inflammation, n (%) | 755 (60.6) | 90 (75.6) |
BMI: body mass index; ART: antiretroviral therapy; SIL: squamous intraepithelial lesions.
a
A Pap smear result was defined as abnormal if it was low-grade SIL (LSIL), high-grade SIL (HSIL) or atypical squamous cells of undetermined significance (ASCUS) by the pathologist.